Home > Insider Trading > Filing (0001883850-22-000058)

Filing Details

Accession Number:: 0001883850-22-000058
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-08-17 16:04:35
Reporting Period:: 2022-08-15

Accepted Time:: 2022-08-17 16:04:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1796226	J Andrew Murphy	777 Old Saw Mill River Road Tarrytown NY 10591	Evp Research	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-08-15	10,000	$179.13	68,470	No	4	M	Direct
Common Stock	Disposition	2022-08-15	6,487	$634.25	61,983	No	4	F	Direct
Common Stock	Disposition	2022-08-16	76	$639.85	61,907	No	4	S	Direct
Common Stock	Disposition	2022-08-16	148	$640.91	61,759	No	4	S	Direct
Common Stock	Disposition	2022-08-16	537	$641.47	61,222	No	4	S	Direct
Common Stock	Disposition	2022-08-16	329	$642.53	60,893	No	4	S	Direct
Common Stock	Disposition	2022-08-16	94	$643.37	60,799	No	4	S	Direct
Common Stock	Disposition	2022-08-16	332	$644.49	60,467	No	4	S	Direct
Common Stock	Disposition	2022-08-16	119	$645.63	60,348	No	4	S	Direct
Common Stock	Disposition	2022-08-16	325	$646.44	60,023	No	4	S	Direct
Common Stock	Disposition	2022-08-16	701	$647.73	59,322	No	4	S	Direct
Common Stock	Disposition	2022-08-16	766	$648.78	58,556	No	4	S	Direct
Common Stock	Disposition	2022-08-16	86	$649.54	58,470	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2022-08-15	10,000	$0.00	10,000	$179.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000		2022-12-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,290	Indirect	By 401(k) Plan

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 148 shares of Company stock on August 16, 2022 at prices ranging from $640.88 to $640.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 537 shares of Company stock on August 16, 2022 at prices ranging from $641.00 to $641.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 329 shares of Company stock on August 16, 2022 at prices ranging from $642.13 to $642.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 94 shares of Company stock on August 16, 2022 at prices ranging from $643.33 to $643.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 332 shares of Company stock on August 16, 2022 at prices ranging from $644.10 to $644.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 119 shares of Company stock on August 16, 2022 at prices ranging from $645.49 to $645.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 325 shares of Company stock on August 16, 2022 at prices ranging from $646.27 to $646.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 701 shares of Company stock on August 16, 2022 at prices ranging from $647.20 to $647.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 766 shares of Company stock on August 16, 2022 at prices ranging from $648.17 to $648.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.